BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34890380)

  • 1. Interferon-gamma inhibits aldehyde dehydrogenasebright cancer stem cells in the 4T1 mouse model of breast cancer.
    Zhuang X; Shi G; Hu X; Wang H; Sun W; Wu Y
    Chin Med J (Engl); 2021 Dec; 135(2):194-204. PubMed ID: 34890380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo.
    Cao Y; Feng YH; Gao LW; Li XY; Jin QX; Wang YY; Xu YY; Jin F; Lu SL; Wei MJ
    Int Immunopharmacol; 2019 May; 70():110-116. PubMed ID: 30798159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-7 enhances the in vivo anti-tumor activity of tumor-reactive CD8+ T cells with induction of IFN-gamma in a murine breast cancer model.
    Yuan CH; Yang XQ; Zhu CL; Liu SP; Wang BC; Wang FB
    Asian Pac J Cancer Prev; 2014; 15(1):265-71. PubMed ID: 24528037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of the IL-37b gene elicits anti-tumor responses in mice bearing 4T1 breast cancer.
    Wang WQ; Zhao D; Zhou YS; Hu XY; Sun ZN; Yu G; Wu WT; Chen S; Kuang JL; Xu GG; Han ZC; Wang BM; Yang JX; Feng XM
    Acta Pharmacol Sin; 2015 Apr; 36(4):528-34. PubMed ID: 25832432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microenvironment of the murine mammary carcinoma 4T1: endogenous IFN-gamma affects tumor phenotype, growth, and metastasis.
    duPre' SA; Redelman D; Hunter KW
    Exp Mol Pathol; 2008 Dec; 85(3):174-88. PubMed ID: 18929358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α.
    Kim RJ; Park JR; Roh KJ; Choi AR; Kim SR; Kim PH; Yu JH; Lee JW; Ahn SH; Gong G; Hwang JW; Kang KS; Kong G; Sheen YY; Nam JS
    Cancer Lett; 2013 Jun; 333(1):18-31. PubMed ID: 23174107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMAR1 promotes immune escape of Tri-negative Breast Cancer through a mechanism involving T-bet/PD-1 Axis.
    Xiaohua W; Hongxia X; Rong D; Pingping W; Xing H; Yichao Z; Cheng C
    Cell Mol Biol (Noisy-le-grand); 2018 Sep; 64(12):70-75. PubMed ID: 30301506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
    Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
    Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model.
    Balog JÁ; Hackler L; Kovács AK; Neuperger P; Alföldi R; Nagy LI; Puskás LG; Szebeni GJ
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1.
    Zhuang X; Zhang W; Chen Y; Han X; Li J; Zhang Y; Zhang Y; Zhang S; Liu B
    BMC Cancer; 2012 Nov; 12():549. PubMed ID: 23176143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma.
    Pulaski BA; Smyth MJ; Ostrand-Rosenberg S
    Cancer Res; 2002 Aug; 62(15):4406-12. PubMed ID: 12154047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of aspirin on breast cancer stem cells and stemness of breast cancer].
    Tu L; Zeng Z; Wang L; Luo F
    Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(44):3598-3602. PubMed ID: 30486577
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of tumor initiation and expression of KCNMA1, MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatment.
    Kuo WY; Wu CY; Hwu L; Lee JS; Tsai CH; Lin KP; Wang HE; Chou TY; Tsai CM; Gelovani J; Liu RS
    Oncotarget; 2015 Apr; 6(11):8663-75. PubMed ID: 25796627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment.
    Han SJ; Sung N; Wang J; O'Malley BW; Lonard DM
    Breast Cancer Res; 2022 Oct; 24(1):73. PubMed ID: 36316775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity.
    Nigjeh SE; Yeap SK; Nordin N; Rahman H; Rosli R
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31492037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
    Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
    Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer.
    Rausch MP; Hahn T; Ramanathapuram L; Bradley-Dunlop D; Mahadevan D; Mercado-Pimentel ME; Runyan RB; Besselsen DG; Zhang X; Cheung HK; Lee WC; Ling LE; Akporiaye ET
    Anticancer Res; 2009 Jun; 29(6):2099-109. PubMed ID: 19528470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer stem-like cells can promote metastasis by activating platelets and down-regulating antitumor activity of natural killer cells.
    Wang S; Zhang Y; Cong W; Liu J; Zhang Y; Fan H; Xu Y; Lin H
    J Tradit Chin Med; 2016 Aug; 36(4):530-7. PubMed ID: 28459521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
    Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
    Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.